期刊文献+

Delta N p63蛋白在膀胱癌组织中的表达及意义 被引量:2

Expression and clinical significance of delta N p63 protein in bladder transitional cell cancer
下载PDF
导出
摘要 目的:探讨DeltaNp63(ΔNp63)蛋白在膀胱移行细胞癌(TCCB)中的表达及意义。方法:采用SP免疫组织化学法检测43例TCCB患者肿瘤组织、11例对照组膀胱组织ΔNp63蛋白的表达,并分析ΔNp63蛋白表达与TCCB临床分期、病理分级的关系。结果:43例TCCB组织中ΔNp63蛋白表达阳性率为100%(43/43),对照组膀胱组织中ΔNp63蛋白表达的阳性率为18.2%(2/11),TCCB组ΔNp63蛋白表达的阳性率明显高于正常组,差异有显著性(P<0.05)。不同临床分期肿瘤组织中ΔNp63蛋白表达的阳性率及强度,各组间ΔNp63蛋白表达的阳性率及表达强度差异无显著性(P>0.05)。不同病理分级肿瘤组织中ΔNp63蛋白表达的阳性率及强度,各组间ΔNp63蛋白表达的阳性率及表达强度差异无显著性(P>0.05)。结论:TC-CB组ΔNp63蛋白表达水平均明显高于正常组,提示ΔNp63与TCCB的发生密切相关,可能为TCCB发生的重要促进因素,ΔNp63蛋白表达水平与TCCB的临床分期、病理分级没有相关性,故ΔNp63在TCCB进展中的作用有待进一步研究。 Objective: to explore the expression and clinical significance of delta N p63 protein in transitional cell carcinoma oI mebladder ( TCCB ). Method: The immunohistochemical staining assay was conducted to detect expression of delta N p63 protein in 43 cases of TCCB and 11 cases of normal bladder epithelium. The relationship between delta N p63 protein expression and pathological types ,clinical stages of TCCB was analyzed. Results:The expression rates of delta N p63 protein in TCCB and normal bladder epithelium were100% ( 43/43 ) and 15.2% ( 2/11 ) respectively. The difference between the two groups was significant ( P〈 0.05 ). There was no significant difference in the expression rate of deha N p63 protein in different pathological types and clinical stages of TCCB, The differences between groups were no significant. Conclusion:There is high expression of delta N p63 protein in TCCB, deha N p63 is associated withtumorigenesis in TCCB, but is not associated with pathological types and clinical stages of TCCB. Further studies will be necessary to explore the function of delta N p63 in the progression of TCCB.
出处 《重庆医科大学学报》 CAS CSCD 2006年第3期311-313,317,共4页 Journal of Chongqing Medical University
基金 重庆市教委基金资助项目(040313)
关键词 膀胱癌 △NP63 Bladder cancer DeliaN p63
  • 相关文献

参考文献10

  • 1Christopher E.Barbierri,Carmen A.Perez,Kimberly N.Johnson,et al.IGFBP-3 is a direct target of transcriptional regulation by A Np63 α in squamous epithelium[J].Cancer Res,2005;65(6):2314-2320.
  • 2Dohn M,zhang S,Chen x.p63 alpha and DeltaNp63alpha can induce cell cycle arrest and poptosis and differentially regulate p53 target genes[J].Oncogene,2001;20(25):3193-3205.
  • 3Robert P.Dellavalle,Patrick Walsh,Angela Marchbank,et al.CUSP/p63 expression in basal cell carcinoma[J].Experimental Dermatology,2002;11(3):203.
  • 4Zeimet-A-G,Marth-C.Why did p53 gene therapy fail in ovarian cancer[J].Lancet-Oncol,2003; 4(7):415-422.
  • 5Zeimet-A-G,Dellavalle,Patrick Walsh,et al.CUSP/p63 expression in basal cell carcinoma[J].Experimental Dermatology,2002; 11 (3):203.
  • 6Bum-Joon Park,Seung-Jae Lee,Jin Il Kim,et al.Frequent Alteration of p63 Expression in Human Primary Bladder Carcinomas[J].Cancer Research,2000;60:3370-3374.
  • 7Karin Nylander,OhiliP J,Coates,et al.Chracterization of the expression Pattern if P63 α and △ NP63 α in being and malignant oral epithelial lesions[J].Int,J Cancer,2000;87:368-372.
  • 8Yamaguchi K,Wu L,Caballero OL,et al.Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma[J].Int J Cancer,2000;86:684-689.
  • 9Marshall J.Urist,Charles J.Di Como,Ming-Lan Lu,et al.Loss of p63 expression is associated with tumor progression in bladder cancer[J].Am-J-Pathol,2002;161 (4):1199-1206.
  • 10F Koga,S Kawakami,J Kumagai,et al.Impaired △ N p63 expression associates with reduced 3-catenin and aggressive phenotypes of urothelial neoplasms[J].British Journal of Cancer,2003;88:740-747.

同被引文献48

  • 1廖义翔,杨为民,叶章群.Cyclin D1、p27、ki-67在膀胱移行细胞癌中的表达及其意义[J].临床外科杂志,2006,14(11):713-715. 被引量:2
  • 2温机灵,周祥福,冯智英,黄文涛,张涛,蔡育彬,高新.p53、p21、Ki-67和VEGF与膀胱癌分级、分期以及预后的关系[J].临床泌尿外科杂志,2007,22(5):328-331. 被引量:14
  • 3De Laurenzi V, Melino G. Evolution of functions within the p53/p63/p73 family[J]. Ann N Y Acad Sci,2000,926:90-100.
  • 4George B, Datar RH, Wu L,etal. p53 gene and protein status.. the role of p53 alterations in predicting outcome in patients with bladder cancer[J]. J Clin Oncol, 2007,25 (34) : 5352-5358.
  • 5Malmstrom PU, Ren ZP, Sherif A,et al. Early metastatic progression of bladder eareinoma: molecular profile of primary tumor and sentinel lymph node[J]. J Urol, 2002,168 (5) : 2240- 2244.
  • 6Shariat SF, Kim J, Rapt idis G, et al. Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder[J]. Urology,2003,61(6):1140-1145.
  • 7Dalbagni G, Parekh DJ, Ben-Porat L, et al. Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder[J]. BJU Int, 2007,99(2) :281-285.
  • 8Melino G, Lu X, Gasco M, et al. Functional regulation of p73 and p63: development and eaneer[J]. Trends Biochem Sei,2003, 28:663-670.
  • 9Urist M J, Di Como CJ, Lu ML, etal. Loss of p63 expression is associated with tumor progression in bladder cancer[J]. Am J Pathol, 2002,161 : 1199-1206.
  • 10He Y, Wu X, Tang W. Impaired delta NP63 expression is assoelated with poor tumor development in transitional cell carcinoma of the bladder[J]. J Korean Med Sci, 2008, 23(5) :825-832.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部